bioMerieux

bioMerieux

BIM.PA
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

BIM.PA · Stock Price

EUR 71.55-44.75 (-38.48%)
Market Cap: $9.9B

Historical price data

Market Cap: $9.9BPatents: 20Founded: 1963Employees: ~13,000HQ: Marcy-l'Étoile, France

Overview

bioMérieux's mission is to make the world a healthier place by pioneering diagnostic solutions that improve patient outcomes and consumer safety. The company has achieved a leading global position through its dual focus on clinical and industrial applications, supported by a robust portfolio anchored in microbiology, immunoassays, and molecular diagnostics. Its strategy centers on continuous R&D investment (~13% of sales), strategic acquisitions like BIOFIRE, and expanding its syndromic testing and point-of-care offerings to address critical healthcare challenges such as AMR and sepsis.

Infectious DiseasesSepsisAntimicrobial ResistanceFood SafetyPharmaceutical Quality Control

Technology Platform

Integrated diagnostics platform encompassing automated microbiology (VITEK), immunoassays (VIDAS/BRAHMS), and multiplex molecular syndromic testing (BIOFIRE FILMARRAY/SPOTFIRE), supported by industrial solutions for food and pharma safety.